FDA Clearance Tracker · K261039
i-STAT Crea cartridge with the i-STAT 1 System
Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jun 26, 2026
Substantially Equivalent
Time to decision
88 days
Received Mar 30, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K261039
- Device name
- i-STAT Crea cartridge with the i-STAT 1 System
- Applicant
- Abbott Point of Care, Inc.
- Applicant location
- Princeton, NJ
- Received
- Mar 30, 2026
- Decided
- Jun 26, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1225
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CGL. The earliest in FDA's data is K903034, decided Mar 13, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K261039
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Abbott Point of Care, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253051 · Decided Jun 11, 2026 · 262 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
K244014 · Decided May 2, 2025 · 127 days after receipt
Device type: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph (CHL) · Laboratory Medicine & Pathology
K240984 · Decided Jan 3, 2025 · 268 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.